Careteq Appoints Pauline Soo to Advisory Board to Support HMR Referrals Growth

Sonal Goyal

06 November 2026 11:23 AM AEDT

Careteq Appoints Pauline Soo to Advisory Board to Support HMR Referrals Growth

Image Source: Krish Capital Pty Ltd

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Careteq Limited (ASX:CTQ) has appointed digital health executive Pauline Soo as a member of its Advisory Board, the clinical healthtech company disclosed on 6 November 2026, with the appointment aimed at supporting the growth and development of its HMR Referrals business.

Key Points

Pauline Soo appointed as a member of Careteq's Advisory Board, effective 6 November 2026
Ms Soo has more than 20 years of experience across healthcare, digital transformation, commercial strategy and operational leadership
She is currently Head of InstantScripts at Wesfarmers Health and previously held senior roles at Datacom and Teladoc Health
Careteq's Advisory Board was established in August 2026 and is chaired by Fiona Rhody-Nicoll
The company said it is progressing further Advisory Board appointments with expertise in artificial intelligence and healthcare technology

Pauline Soo's Professional Background and Current Role

According to the filing, Ms Soo currently serves as Head of InstantScripts at Wesfarmers Health, where she has led the integration and evolution of the digital healthcare business, including initiatives spanning clinical governance, operational scalability and AI-enabled healthcare services. Her previous senior leadership roles include Director – Health ANZ at Datacom and Director of Operations, Australasia at Teladoc Health. She also serves on the Calvary Health Care Bethlehem (Victoria) Advisory Board and previously acted as a sector partner advisor for the Australian Government's Department of Health and Aged Care's Aged Care Digital Transformation Group.

Advisory Board Establishment and Chair's Statement

Careteq's Advisory Board was established in August 2026, chaired by Fiona Rhody-Nicoll, to provide strategic guidance on commercial expansion, technology innovation, healthcare partnerships and growth opportunities. Advisory Board Chair Ms Rhody-Nicoll said Ms Soo brings "a strong combination of digital health expertise, commercial acumen and operational leadership" and that her experience with leading healthcare and technology organisations "will provide valuable insights as we work with management to identify new growth opportunities, strengthen strategic partnerships and support the continued evolution of HMR Referrals."

Further Advisory Board Appointments Planned

The company disclosed it is progressing the appointment of additional Advisory Board members with complementary expertise across artificial intelligence and healthcare technology, with further appointments to be announced in accordance with the company's continuous disclosure obligations. Executive Chairman Mark Simari said the company is "strengthening our ability to identify new opportunities, accelerate growth and build a more scalable healthcare technology business" by bringing together experienced healthcare leaders with industry relationships and expertise in digital innovation. Careteq operates HMR Referrals, a marketplace platform that streamlines the process of completing Home Medicines Reviews.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.